lobbying_activities: 988225

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
988225	b81a2c08-af8b-4142-8908-af13af66fa95	Q3	DALRYMPLE & ASSOCIATES, LLC	5073	EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION)	2010	third_quarter	DEF	Anthrax vaccine and immunoglobulin research, acquisition, immunization, legislation, funding, appropriations and oversight.	Army, Dept of (Other),Ballistic Missile Defense Organization,Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office	47000		0	0	2010-10-06T13:24:07.167000-04:00